Laurus Labs Limited
LAURUSLABS
Helyezés a részvények között
#1779
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Részvényárfolyam
$22.25
Piaci kapitalizáció
$12.02B
Változás (1 nap)
-2.57%
Változás (1 év)
111.95%
Ország
IN
Kereskedés Laurus Labs Limited (LAURUSLABS)
Kategória
Healthcare
Laurus Labs Limited (LAURUSLABS) P/B aránya
P/B arány ekkor: October 2026 TTM: 20.22
Laurus Labs Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 20.22. 2024 végén ez az arány 5.33 volt.
P/B arány története a(z) Laurus Labs Limited esetén 2013 és 2026 között
P/B arány az év végén
| Év | P/B arány | Változtassa meg |
|---|---|---|
| 2026 (TTM) | 20.22 | 179.62% |
| 2025 | 7.23 | 35.60% |
| 2024 | 5.33 | 36.58% |
| 2023 | 3.90 | -58.72% |
| 2022 | 9.45 | 26.60% |
| 2021 | 7.47 | 281.34% |
| 2020 | 1.96 | -27.51% |
| 2019 | 2.70 | -25.65% |
| 2018 | 3.63 | 3.43% |
| 2017 | 3.51 | -22.67% |
| 2016 | 4.54 | 10.34% |
| 2015 | 4.12 | -49.81% |
| 2014 | 8.20 | -45.55% |
| 2013 | 15.06 | 0.00% |
P/B arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/B arány | P/B arány különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -75.07% |
IN
|
